Heron Therapeutics | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
ALKERMES USD 1.51B 46.61M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amarin USD 473.69M 12.49M 2025-03
ANI Pharmaceuticals USD 418.62M 14.94M 2025-03
Arrowhead Research USD 684.22M 631.64M 2025-03
Eisai JPY 841.42B 31.94B 2025-03
GlaxoSmithKline GBP 14.16B 486M 2025-03
Insmed USD 99.16M 186.22M 2025-03
Ligand Pharmaceuticals USD 795.53M 34.9M 2025-03
Merck USD 48.34B 2.02B 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Pacira USD 798.54M 20.19M 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
Veracyte USD 1.19B 18.97M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Heron Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.